• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    AstraZeneca Pharma India Limited — Updates, 10-04-2026: General Updates

    10-04-2026 | 05:48 pm

    AstraZeneca India received drug regulator approval for expanded use of Calquence® (Acalabrutinib) tablets. This enables marketing for previously untreated chronic lymphocytic leukaemia/small lymphocytic lymphoma, broadening its market potential.

    No comments yet. Be the first to comment!

    All announcements from AstraZeneca Pharma India Limited